The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn

The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn

Since 2003, FEBS Letters has awarded an annual prize to the corresponding author of the best research paper published in the journal in the previous calendar year. The award‐winning article is selected by a special committee formed by appointed members of the Editorial Board, plus one external membe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:FEBS letters 2024-10, Vol.598 (20), p.2467-2469
Hauptverfasser: Flynn, Rachel Litman, Wright, Duncan E.
Format: Artikel
Sprache:eng
Schlagworte:
exoribonucleases
medicine
RNA
telomeres
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2469
container_issue 20
container_start_page 2467
container_title FEBS letters
container_volume 598
creator Flynn, Rachel Litman
Wright, Duncan E.
description Since 2003, FEBS Letters has awarded an annual prize to the corresponding author of the best research paper published in the journal in the previous calendar year. The award‐winning article is selected by a special committee formed by appointed members of the Editorial Board, plus one external member. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian & Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian & Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research.
doi_str_mv 10.1002/1873-3468.15031
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153839988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153839988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3021-ee3bbfc06bb4f25d5ad3db1637b2e64e45cc044f4de9ba280f5e76df71f62de53</originalsourceid><addsrcrecordid>eNqNkLtOwzAUhi0EoqUwsyGPLGl9zWUsVctFlZCgzFYSH6tBaVLslKgbD8ET8iS4pHSF6eg_-v5_-BC6pGRICWEjGkc84CKMh1QSTo9Q__A5Rn1CqAhklPAeOnPulfgc0-QU9XjCI0njpI8eFkvAbVFVYHFtcOMTI0zg2fTmGc-hacA6PG5Tq78-PtMKF5X_vBfQ-lKzxE9pvoQSz8ptVZ2jE5OWDi72d4BeZtPF5C6YP97eT8bzIOeE0QCAZ5nJSZhlwjCpZaq5zmjIo4xBKEDIPCdCGKEhyVIWEyMhCrWJqAmZBskH6LrbXdv6bQOuUavC5VCWaQX1xilOJY95ksTxP1AqqKSCRR4ddWhua-csGLW2xSq1W0WJ2rlWO7NqZ1b9uPaNq_34JluBPvC_cj0QdkBblLD9a0955axb_gbT1YfD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3114151427</pqid></control><display><type>article</type><title>The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Flynn, Rachel Litman ; Wright, Duncan E.</creator><creatorcontrib>Flynn, Rachel Litman ; Wright, Duncan E.</creatorcontrib><description>Since 2003, FEBS Letters has awarded an annual prize to the corresponding author of the best research paper published in the journal in the previous calendar year. The award‐winning article is selected by a special committee formed by appointed members of the Editorial Board, plus one external member. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian &amp; Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian &amp; Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research.</description><identifier>ISSN: 0014-5793</identifier><identifier>ISSN: 1873-3468</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1002/1873-3468.15031</identifier><identifier>PMID: 39375189</identifier><language>eng</language><publisher>England</publisher><subject>exoribonucleases ; medicine ; RNA ; telomeres</subject><ispartof>FEBS letters, 2024-10, Vol.598 (20), p.2467-2469</ispartof><rights>2024 Federation of European Biochemical Societies.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0008-7874-2422 ; 0000-0003-0562-1909</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1873-3468.15031$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1873-3468.15031$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39375189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flynn, Rachel Litman</creatorcontrib><creatorcontrib>Wright, Duncan E.</creatorcontrib><title>The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>Since 2003, FEBS Letters has awarded an annual prize to the corresponding author of the best research paper published in the journal in the previous calendar year. The award‐winning article is selected by a special committee formed by appointed members of the Editorial Board, plus one external member. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian &amp; Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian &amp; Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research.</description><subject>exoribonucleases</subject><subject>medicine</subject><subject>RNA</subject><subject>telomeres</subject><issn>0014-5793</issn><issn>1873-3468</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkLtOwzAUhi0EoqUwsyGPLGl9zWUsVctFlZCgzFYSH6tBaVLslKgbD8ET8iS4pHSF6eg_-v5_-BC6pGRICWEjGkc84CKMh1QSTo9Q__A5Rn1CqAhklPAeOnPulfgc0-QU9XjCI0njpI8eFkvAbVFVYHFtcOMTI0zg2fTmGc-hacA6PG5Tq78-PtMKF5X_vBfQ-lKzxE9pvoQSz8ptVZ2jE5OWDi72d4BeZtPF5C6YP97eT8bzIOeE0QCAZ5nJSZhlwjCpZaq5zmjIo4xBKEDIPCdCGKEhyVIWEyMhCrWJqAmZBskH6LrbXdv6bQOuUavC5VCWaQX1xilOJY95ksTxP1AqqKSCRR4ddWhua-csGLW2xSq1W0WJ2rlWO7NqZ1b9uPaNq_34JluBPvC_cj0QdkBblLD9a0955axb_gbT1YfD</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Flynn, Rachel Litman</creator><creator>Wright, Duncan E.</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0009-0008-7874-2422</orcidid><orcidid>https://orcid.org/0000-0003-0562-1909</orcidid></search><sort><creationdate>202410</creationdate><title>The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn</title><author>Flynn, Rachel Litman ; Wright, Duncan E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3021-ee3bbfc06bb4f25d5ad3db1637b2e64e45cc044f4de9ba280f5e76df71f62de53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>exoribonucleases</topic><topic>medicine</topic><topic>RNA</topic><topic>telomeres</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flynn, Rachel Litman</creatorcontrib><creatorcontrib>Wright, Duncan E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flynn, Rachel Litman</au><au>Wright, Duncan E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>2024-10</date><risdate>2024</risdate><volume>598</volume><issue>20</issue><spage>2467</spage><epage>2469</epage><pages>2467-2469</pages><issn>0014-5793</issn><issn>1873-3468</issn><eissn>1873-3468</eissn><abstract>Since 2003, FEBS Letters has awarded an annual prize to the corresponding author of the best research paper published in the journal in the previous calendar year. The award‐winning article is selected by a special committee formed by appointed members of the Editorial Board, plus one external member. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian &amp; Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research. The winner of the 2024 FEBS Letters Award is Professor Rachel Flynn of Boston University Chobanian &amp; Avedisian School of Medicine, for the outstanding paper “The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA.” In this interview, Rachel Flynn talks about her award‐winning research.</abstract><cop>England</cop><pmid>39375189</pmid><doi>10.1002/1873-3468.15031</doi><tpages>3</tpages><orcidid>https://orcid.org/0009-0008-7874-2422</orcidid><orcidid>https://orcid.org/0000-0003-0562-1909</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-5793
ispartof FEBS letters, 2024-10, Vol.598 (20), p.2467-2469
issn 0014-5793
1873-3468
1873-3468
language eng
recordid cdi_proquest_miscellaneous_3153839988
source Wiley Online Library Journals Frontfile Complete
subjects exoribonucleases
medicine
RNA
telomeres
title The winner of the 2024 FEBS Letters Award—an interview with Rachel Flynn
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A32%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20winner%20of%20the%202024%20FEBS%20Letters%20Award%E2%80%94an%20interview%20with%20Rachel%20Flynn&rft.jtitle=FEBS%20letters&rft.au=Flynn,%20Rachel%20Litman&rft.date=2024-10&rft.volume=598&rft.issue=20&rft.spage=2467&rft.epage=2469&rft.pages=2467-2469&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1002/1873-3468.15031&rft_dat=%3Cproquest_cross%3E3153839988%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3114151427&rft_id=info:pmid/39375189&rfr_iscdi=true